Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-13

Clinical Trial Update: Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on PBF-677 for ulcerative colitis reports safety and efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PBF-677

Snippet

Sponsor: Palobiofarma SL | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED